These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18790303)

  • 1. Voclosporin (ISA247) for plaque psoriasis.
    Naidoo P; Rambiritch V
    Lancet; 2008 Sep; 372(9642):888-9; author reply 889. PubMed ID: 18790303
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.
    Papp K; Bissonnette R; Rosoph L; Wasel N; Lynde CW; Searles G; Shear NH; Huizinga RB; Maksymowych WP
    Lancet; 2008 Apr; 371(9621):1337-42. PubMed ID: 18424323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.
    Bissonnette R; Papp K; Poulin Y; Lauzon G; Aspeslet L; Huizinga R; Mayo P; Foster RT; Yatscoff RW; Maksymowych WP;
    J Am Acad Dermatol; 2006 Mar; 54(3):472-8. PubMed ID: 16488299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic calcineurin inhibitors tacrolimus and voclosporin: A review of off-label dermatologic uses.
    Dai A; Kim SJ
    J Am Acad Dermatol; 2024 Feb; 90(2):358-367. PubMed ID: 37307993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study.
    Kunynetz R; Carey W; Thomas R; Toth D; Trafford T; Vender R
    Eur J Dermatol; 2011; 21(1):89-94. PubMed ID: 21227890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Guidelines for the Use of Cyclosporine for Psoriasis: A Critical Appraisal and Comprehensive Review.
    Soleymani T; Vassantachart JM; Wu JJ
    J Drugs Dermatol; 2016 Mar; 15(3):293-301. PubMed ID: 26954314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine A in psoriasis.
    Rebora A
    Clin Dermatol; 1991; 9(4):515-22. PubMed ID: 1822409
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic voclosporin for uveitis treatment].
    Deuter CM
    Ophthalmologe; 2010 Jul; 107(7):672-5. PubMed ID: 20571806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for effective and safe disease control in psoriasis.
    Naldi L
    Lancet; 2008 Apr; 371(9621):1311-2. PubMed ID: 18424307
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclosporine and psoriasis].
    Mazer JM
    Rev Prat; 1991 Oct; 41(22):2183-4. PubMed ID: 1784921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine in the treatment of psoriasis.
    Gulliver WP
    Cutis; 2000 Nov; 66(5):365-9. PubMed ID: 11107522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine in dermatology. Fears and opportunities.
    Koo J
    Arch Dermatol; 1995 Jul; 131(7):842-5. PubMed ID: 7611807
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine: what clinicians need to know.
    Koo J; Lee J
    Dermatol Clin; 1995 Oct; 13(4):897-907. PubMed ID: 8785893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclosporine and psoriasis: experience with 14 patients].
    Gajardo J
    Rev Med Chil; 1993 Dec; 121(12):1411-5. PubMed ID: 8085065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are concerns about the ethics of placebos a stalking horse for other issues?
    Healy D
    Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
    Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
    Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical immunotherapy in patients with psoriasis.
    Amerio P; Gravante M; Andreassi M; Masci S
    Acta Derm Venereol Suppl (Stockh); 1994; 186():101-2. PubMed ID: 8073801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.